Other Healthy LInks:
-------------------------------
Chronic Toxicity Study Confirms Safety of
Bio-Phase 2250™
Ingredient
Investigation of the efficacy of
Bio-Phase 2250™
, a purified bean extract
Summary of clinical study evaluating effectiveness of
Bio-Phase 2250™
In vivo effectiveness of a starch absorption blocker in a double-blind placebo- controlled study with normal college-age subjects
Bio-Phase 2250™
Demonstrates Efficacy When Taken With a Mixed Full Meal
In vivo effectiveness of a starch absorption blocker in a double-blind placebo-
controlled study with normal subjects
Structure of an alpha-amylase inhibitor produced by marine actinomycete and its lowering effects in vivo of glucose and lipid in blood
Evaluation of the efficacy of an amylase inhibitor
Characterization and functional properties of the alpha-amylase inhibitor (alpha-AI) from kidney bean (Phaseolus vulgaris) seeds
A putative precursor protein in the evolution of the bean alpha-amylase inhibitor
Character of a wheat amylase inhibitor preparation and effects on fasting human pancreaticobiliary secretions and hormones
Partially purified white bean amylase inhibitor reduces starch digestion in vitro and inactivates intraduodenal amylase in humans
A bean alpha-amylase inhibitor formulation (starch blocker) is ineffective in man
Purification and properties of
Bio-Phase 2250™
, an inhibitor of alpha-amylase, from the kidney bean, Phaseolus vulgaris.
